267 related articles for article (PubMed ID: 28848433)
1. Role of Proteases in Chronic Obstructive Pulmonary Disease.
Pandey KC; De S; Mishra PK
Front Pharmacol; 2017; 8():512. PubMed ID: 28848433
[TBL] [Abstract][Full Text] [Related]
2. Elevated serum matrix metalloprotease (MMP-2) as a candidate biomarker for stable COPD.
Mahor D; Kumari V; Vashisht K; Galgalekar R; Samarth RM; Mishra PK; Banerjee N; Dixit R; Saluja R; De S; Pandey KC
BMC Pulm Med; 2020 Nov; 20(1):302. PubMed ID: 33198714
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
Abboud RT; Vimalanathan S
Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
[TBL] [Abstract][Full Text] [Related]
4. [Proteases involved in airway inflammation of COPD].
Kasagi S; Seyama K; Fukuchi Y
Nihon Rinsho; 2003 Dec; 61(12):2113-8. PubMed ID: 14674319
[TBL] [Abstract][Full Text] [Related]
5. The Serpin Superfamily and Their Role in the Regulation and Dysfunction of Serine Protease Activity in COPD and Other Chronic Lung Diseases.
Kelly-Robinson GA; Reihill JA; Lundy FT; McGarvey LP; Lockhart JC; Litherland GJ; Thornbury KD; Martin SL
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198546
[TBL] [Abstract][Full Text] [Related]
6. Competition between elastase and related proteases from human neutrophil for binding to alpha1-protease inhibitor.
Korkmaz B; Poutrain P; Hazouard E; de Monte M; Attucci S; Gauthier FL
Am J Respir Cell Mol Biol; 2005 Jun; 32(6):553-9. PubMed ID: 15764720
[TBL] [Abstract][Full Text] [Related]
7. TAILS proteomics reveals dynamic changes in airway proteolysis controlling protease activity and innate immunity during COPD exacerbations.
Mallia-Milanes B; Dufour A; Philp C; Solis N; Klein T; Fischer M; Bolton CE; Shapiro S; Overall CM; Johnson SR
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L1003-L1014. PubMed ID: 30284925
[TBL] [Abstract][Full Text] [Related]
8. Protease-Antiprotease Imbalance in Bronchiectasis.
Oriano M; Amati F; Gramegna A; De Soyza A; Mantero M; Sibila O; Chotirmall SH; Voza A; Marchisio P; Blasi F; Aliberti S
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206113
[TBL] [Abstract][Full Text] [Related]
9. Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases.
Guarino C; Hamon Y; Croix C; Lamort AS; Dallet-Choisy S; Marchand-Adam S; Lesner A; Baranek T; Viaud-Massuard MC; Lauritzen C; Pedersen J; Heuzé-Vourc'h N; Si-Tahar M; Fıratlı E; Jenne DE; Gauthier F; Horwitz MS; Borregaard N; Korkmaz B
Biochem Pharmacol; 2017 May; 131():52-67. PubMed ID: 28193451
[TBL] [Abstract][Full Text] [Related]
10. The Role of Computed Tomography for the Evaluation of Lung Disease in Alpha-1 Antitrypsin Deficiency.
Campos MA; Diaz AA
Chest; 2018 May; 153(5):1240-1248. PubMed ID: 29175361
[TBL] [Abstract][Full Text] [Related]
11. Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatment.
Demkow U; van Overveld FJ
Eur J Med Res; 2010 Nov; 15 Suppl 2(Suppl 2):27-35. PubMed ID: 21147616
[TBL] [Abstract][Full Text] [Related]
12. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites.
Cooley J; Takayama TK; Shapiro SD; Schechter NM; Remold-O'Donnell E
Biochemistry; 2001 Dec; 40(51):15762-70. PubMed ID: 11747453
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease.
Chalmers JD; Kettritz R; Korkmaz B
Front Immunol; 2023; 14():1239151. PubMed ID: 38162644
[TBL] [Abstract][Full Text] [Related]
14. Altered protease and antiprotease balance during a COPD exacerbation contributes to mucus obstruction.
Chillappagari S; Preuss J; Licht S; Müller C; Mahavadi P; Sarode G; Vogelmeier C; Guenther A; Nahrlich L; Rubin BK; Henke MO
Respir Res; 2015 Jul; 16(1):85. PubMed ID: 26169056
[TBL] [Abstract][Full Text] [Related]
15. Functional significance of apoptosis in chronic obstructive pulmonary disease.
Park JW; Ryter SW; Choi AM
COPD; 2007 Dec; 4(4):347-53. PubMed ID: 18027162
[TBL] [Abstract][Full Text] [Related]
16. A mathematical model of protease-antiprotease homeostasis failure in chronic obstructive pulmonary disease (COPD).
Cox LA
Risk Anal; 2009 Apr; 29(4):576-86. PubMed ID: 19000077
[TBL] [Abstract][Full Text] [Related]
17. Proteases and antiproteases.
Stockley RA
Novartis Found Symp; 2001; 234():189-99; discussion 199-204. PubMed ID: 11199096
[TBL] [Abstract][Full Text] [Related]
18. Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.
Janciauskiene S; Welte T
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S280-8. PubMed ID: 27564662
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil elastase inhibitors.
Groutas WC; Dou D; Alliston KR
Expert Opin Ther Pat; 2011 Mar; 21(3):339-54. PubMed ID: 21235378
[TBL] [Abstract][Full Text] [Related]
20. Targeting COPD: advances on low-molecular-weight inhibitors of human neutrophil elastase.
Lucas SD; Costa E; Guedes RC; Moreira R
Med Res Rev; 2013 Jun; 33 Suppl 1():E73-101. PubMed ID: 21681767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
